Ultragenyx Pharmaceutical (RARE) Q1 2022 Earnings

10FebConfirmed
Q2 2021
Q3 2021
Q4 2021
Q1 2022
-2.03
-1.71
-1.4
-1.08

Details

Expected EPS
-1.28
Actual EPS
-1.79
Surprise EPS
-0.51
Surprise Percent
+39.84%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.79 per share for Q1 2022.

0 Comments

Share your thoughts